Speech-Language Pathologists in Marysville, WA Accepting Medicare

32 Speech-Language Pathologists found. Showing 1 - 20

Deborah Bradley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-0896

Dr. Paul Morphy, PHD CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6325 91st St Ne, Marysville, WA 98270 Phone: 360-965-1966

Graham Lucas Chattin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-965-0000

Miss Barbara Andrea Herrera Rojas, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14500 51st Ave Ne, Marysville, WA 98271 Phone: 360-965-8687

Marysville School District Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th Street Ne, Marysville School District, Marysville, WA 98270 Phone: 360-653-7058    Fax: 360-657-6824

Maryann Walters Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-7058

Caitlin Schauer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4407 116th St Ne, Marysville, WA 98271 Phone: 360-965-1649

Anna Rapacz, M.A. SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4317 76th St Ne, Marysville, WA 98270 Phone: 360-965-0257

Kaija Bergdale Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4317 76th St Ne, Marysville, WA 98270 Phone: 360-965-0225

Ms. Kathleen Fitzpatrick, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-657-6734

Lacey Aylesworth Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3905 87th Ave Ne, Marysville, WA 98270 Phone: 425-350-5223

Lenell Lane Jumalon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 541-646-1887

Taylor Lindbloom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4317 76th St Ne, Marysville, WA 98270 Phone: 360-965-0225

Mrs. Vivian Ann Brade, MSPA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4407 116th St Ne, Marysville, WA 98271 Phone: 360-657-6657    Fax: 360-657-6658

Jenna Tippets Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-7058

Mrs. Carole Ann Barton, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-7058    Fax: 360-629-1993

Anitha Simon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6325 91st St Ne, Marysville, WA 98270 Phone: 360-965-1900

Mrs. Nicola Marie Cram, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1821 Grove St, Marysville, WA 98270 Phone: 360-659-3926

Miss Jacqueline Lopez, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-657-6415

Savannah Joy Cuneo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7622 44th Ave Ne, Marysville, WA 98270 Phone: 360-965-3300

News Archive

Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

University of Cincinnati research published in the Sept. 14, 2011, advance online edition of the New England Journal of Medicine shows that patients with hepatitis C who took a combination medication-a telaprevir-based regimen that is commonly used to treat the illness-for 24 weeks were cured.

Stem cell transplantation prevents decrease in heart function associated with DMD

Researchers have shown that transplanting stem cells derived from normal mouse blood vessels into the hearts of mice that model the pathology associated with Duchenne muscular dystrophy (DMD) prevents the decrease in heart function associated with DMD.

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

Researchers investigate challenges involved with robots working in manufacturing plants, homes

Two researchers in the pioneering Robotics Engineering Program at Worcester Polytechnic Institute (WPI) have received awards through the National Science Foundation's (NSF) National Robotics Initiative to investigate and overcome fundamental challenges involved with robots working alongside people in settings such as manufacturing plants and the homes of the elderly.

Read more Medical News

› Verified 9 days ago

• 1(current)
• 2